Co-Artesiane Nigeria - engelsk - NAFDAC (National Agency for Food and Drugs Administration and Control)

co-artesiane

dafra pharma gmbh - artemether 180mg, lumefantrine 1080mg - co-artesiane is indicated for the treatment of malaria in children, caused by all forms of plasmodium including severe malaria caused by multiple drug resistant strains of p. falciparum. in case of a p. vivax malaria infection an additional treatment with primaquine may be required.

Co-Trimoxazol Aurobindo 480 mg, tabletten Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

co-trimoxazol aurobindo 480 mg, tabletten

aurobindo pharma b.v. baarnsche dijk 1 3741 ln baarn - sulfamethoxazol ; trimethoprim ; samenstelling overeenkomend met co-trimoxazolum (ln) - tablet - cellulose, microkristallijn (e 460) ; magnesiumstearaat (e 470b) ; maÏszetmeel ; povidon (e 1201), - sulfamethoxazole and trimethoprim

Co-Trimoxazol Aurobindo forte 960 mg, tabletten Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

co-trimoxazol aurobindo forte 960 mg, tabletten

aurobindo pharma b.v. baarnsche dijk 1 3741 ln baarn - sulfamethoxazol ; trimethoprim ; samenstelling overeenkomend met co-trimoxazolum (ln) - tablet - magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; natriumzetmeelglycolaat ; povidon (e 1201), magnesiumstearaat (e 470b) ; natriumlaurilsulfaat (e 487) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - sulfamethoxazole and trimethoprim

Co-trimoxazol Forte Accord 800/160 mg, tabletten Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

co-trimoxazol forte accord 800/160 mg, tabletten

accord healthcare b.v. winthontlaan 200 3526 kv utrecht - sulfamethoxazol ; trimethoprim ; samenstelling overeenkomend met co-trimoxazolum (ln) - tablet - cellulose, microkristallijn (e 460) ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat ; starch, pregelatinised (not from wheat starch), cellulose, microkristallijn (e 460) ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat (e468) ; starch, pregelatinised (not from wheat starch), - sulfamethoxazole and trimethoprim

CO-DIOVAN 8012.5 MG FILM COATED TABLETS Israel - engelsk - Ministry of Health

co-diovan 8012.5 mg film coated tablets

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

CO-DIOVAN 16012.5 MG FILM-COATED TABLETS Israel - engelsk - Ministry of Health

co-diovan 16012.5 mg film-coated tablets

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

CO-DIOVAN 16025 MG FILM-COATED TABLETS Israel - engelsk - Ministry of Health

co-diovan 16025 mg film-coated tablets

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

CO-DIOVAN 320/25 mg valsartan 320 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

co-diovan 320/25 mg valsartan 320 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

co-diovan 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; microcrystalline cellulose; magnesium stearate; hypromellose; purified talc; iron oxide red; macrogol 4000; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

co-diovan 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; iron oxide red; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.